Since reduced PTEN levels have been reported in CLL, as well as in DLBCL [45, 46], we measured PTEN expression in the primary CLL samples and DLBCL cell lines used in this study. The gene discussed is PTEN; the disease is diffuse large B-cell lymphoma.